Combination of Multidisciplinary Therapies Successfully Treated Refractory Ventricular Arrhythmia in a STEMI Patient: Case Report and Literature Review.
Nung-Sheng LinYen-Yue LinYung-Hsi KaoChin-Pin ChuuKuo-An WuJenq-Shyong ChanPo-Jen HsiaoPublished in: Healthcare (Basel, Switzerland) (2022)
Ventricular fibrillation (VF) is a life-threatening cardiac arrhythmia that can lead to loss of cardiac function and sudden cardiac death. The most common cause of VF is ischemic cardiomyopathy, especially in the context of an acute coronary event. Prompt treatment with resuscitation and defibrillation can be lifesaving. Refractory VF, or pulseless ventricular tachycardia (pVT), refers to cases that do not respond to traditional advanced cardiac life-support (ACLS) measures, and it has a low survival rate. Some new life-saving interventions and novel techniques have been proposed as viable treatment options for patients presenting with refractory VF/pVT out-of-hospital cardiac arrest; these include extracorporeal membrane oxygenation (ECMO), esmolol, stellate ganglion block (SGB), and double sequential defibrillation (DSD). Recently, DSD has been discussed and used more frequently, but its survival rate is still not promising. We report a case of refractory VF caused by acute myocardial infarction that was treated with ACLS, DSD, ECMO, and cardiac catheterization in sequence, with a successful outcome.
Keyphrases
- extracorporeal membrane oxygenation
- left ventricular
- respiratory failure
- acute respiratory distress syndrome
- cardiac arrest
- acute myocardial infarction
- heart failure
- catheter ablation
- percutaneous coronary intervention
- cardiopulmonary resuscitation
- aortic stenosis
- mechanical ventilation
- coronary artery disease
- coronary artery
- ischemia reperfusion injury
- atrial fibrillation
- spinal cord
- acute coronary syndrome
- quality improvement
- intensive care unit
- blood brain barrier
- spinal cord injury
- aortic dissection
- replacement therapy